Literature DB >> 17287648

Cardiac phase-resolved blood oxygen-sensitive steady-state free precession MRI for evaluating the functional significance of coronary artery stenosis.

Rohan Dharmakumar1, Jain Mangalathu Arumana, Andrew C Larson, Yiucho Chung, Graham A Wright, Debiao Li.   

Abstract

OBJECTIVE: This study investigates whether cardiac phase-resolved steady-state free precession (SSFP) magnetic resonance imaging can be used to detect regional myocardial oxygen deficits (MODs) and other functional changes (wall motion and ejection fraction) caused by coronary artery stenosis in a canine model.
MATERIALS AND METHODS: Subsequent to changing the degree of stenosis of the left circumflex arteries of 8 dogs, cardiac phase-resolved SSFP images were acquired at baseline, prestensois (with adenosine), and at different stenosis levels and were correlated against true flow changes. Wall motion and ejection fraction changes also were assessed under the different stenosis levels.
RESULTS: MODs caused by coronary stenosis were observed with the SSFP-based technique and were strongly correlated with microsphere-based regional flow measurements (r=0.80, P<0.01). From the phase-resolved SSFP images, statistically significant (P < 0.01) changes in wall motion and ejection fraction were also observed at severe stenosis.
CONCLUSION: The SSFP method can simultaneously detect MODs, wall motion changes, and left ventricular dysfunction caused by coronary artery stenosis within a single scan in a controlled canine model.

Entities:  

Mesh:

Year:  2007        PMID: 17287648     DOI: 10.1097/01.rli.0000254407.26068.54

Source DB:  PubMed          Journal:  Invest Radiol        ISSN: 0020-9996            Impact factor:   6.016


  8 in total

Review 1.  Three-dimensional contrast-enhanced and non-contrast-enhanced cardiac magnetic resonance imaging for the assessment of myocardial ischemic reactions: the practice of looking deeply into the myocardium.

Authors:  Cosima Jahnke; Sebastian Kozerke; Bernhard Schnackenburg; Nikolaus Marx; Ingo Paetsch
Journal:  J Nucl Cardiol       Date:  2011-10       Impact factor: 5.952

2.  Ischemic extent as a biomarker for characterizing severity of coronary artery stenosis with blood oxygen-sensitive MRI.

Authors:  Sotirios A Tsaftaris; Richard Tang; Xiangzhi Zhou; Debiao Li; Rohan Dharmakumar
Journal:  J Magn Reson Imaging       Date:  2012-01-13       Impact factor: 4.813

3.  Artifact-reduced two-dimensional cine steady state free precession for myocardial blood- oxygen-level-dependent imaging.

Authors:  Xiangzhi Zhou; Sotirios A Tsaftaris; Ying Liu; Richard Tang; Rachel Klein; Sven Zuehlsdorff; Debiao Li; Rohan Dharmakumar
Journal:  J Magn Reson Imaging       Date:  2010-04       Impact factor: 4.813

4.  Oxygenation-sensitive CMR for assessing vasodilator-induced changes of myocardial oxygenation.

Authors:  Matthias Vöhringer; Jacqueline A Flewitt; Jordin D Green; Rohan Dharmakumar; Jiun Wang; John V Tyberg; Matthias G Friedrich
Journal:  J Cardiovasc Magn Reson       Date:  2010-03-31       Impact factor: 5.364

Review 5.  Quantification of myocardial perfusion by cardiovascular magnetic resonance.

Authors:  Michael Jerosch-Herold
Journal:  J Cardiovasc Magn Reson       Date:  2010-10-08       Impact factor: 5.364

6.  Parametric dependence of myocardial blood oxygen level dependent, balanced steady-state free-precession imaging at 1.5 T: theory and experiments.

Authors:  Xiangzhi Zhou; Richard Tang; Rachel Klein; Debiao Li; Rohan Dharmakumar
Journal:  Magn Reson Med       Date:  2010-02       Impact factor: 4.668

7.  CMR-based blood oximetry via multi-parametric estimation using multiple T2 measurements.

Authors:  Juliet Varghese; Lee C Potter; Richard LaFountain; Xueliang Pan; Subha V Raman; Rizwan Ahmad; Orlando P Simonetti
Journal:  J Cardiovasc Magn Reson       Date:  2017-11-09       Impact factor: 5.364

Review 8.  Oxygenation-sensitive cardiovascular magnetic resonance.

Authors:  Matthias G Friedrich; Theodoros D Karamitsos
Journal:  J Cardiovasc Magn Reson       Date:  2013-05-24       Impact factor: 5.364

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.